Abstract:Members of AKT kinase family are central modulators in numerous signaling cascades, which regulate metabolism, cell proliferation, survival and growth. Previously, the knockdown of AKT2 expression has been demonstrated to enhance the efficacy of chemotherapy in patients with osteosarcoma. However, it is currently unknown whether the aberrant expression of AKT2 has relevance to the progression of osteosarcoma. The aim of the present study was to investigate the clinicopathological and prognostic value of AKT2 in osteosarcoma. Formalin-fixed paraffin embedded osteosarcoma and self-paired non-cancerous bone tissue samples were obtained from 126 patients with osteosarcomas. AKT2 expression was detected by an immunohistochemistry assay. Patient survival rates were determined by the Kaplan-Meier method and log-rank test. Cox regression was adopted for multivariate analysis of the prognostic factors to examine the effect of AKT on event-free survival and overall survival in patients with osteosarcomas. AKT2 expression in osteosarcoma tissues was significantly higher than that in non-cancerous bone tissues (immunostaining score, 6.39 +/- 1.62 vs. 3.46 +/- 1.03; P<0.001). In addition, the elevated expression of AKT2 protein was significantly associated with positive recurrence (P=0.023), the presence of metastasis (P=0.006) and poor response to chemotherapy (P=0.015). Furthermore, patients with high AKT2 expression had significantly shorter event-free survival (P<0.001) and overall survival times (P<0.001) than those with lower expression levels. Multivariate analysis further demonstrated that AKT2 expression (P=0.029 and 0.016, respectively), the status of recurrence (P=0.018 and 0.012, respectively) and metastasis (P=0.020 and 0.015, respectively), and the response to chemotherapy (P=0.011 and 0.008, respectively) were all independent prognostic factors for event-free survival and overall survival time. To the best of our knowledge, these data have supported the findings for the first time, that the elevated expression of AKT2 may be associated with aggressive clinical behavior and poor outcome in patients with osteosarcomas. Therefore, AKT2 may be a candidate marker of unfavorable prognosis in osteosarcoma.

BMPR2 and HIF1-α Overexpression in Resected Osteosarcoma Correlates with Distant Metastasis and Patient Survival

Expression of BMP-2 in Osteosarcoma of the Jaw Bone and Its Clinical Significance

The Expression of BMP-2mRNA in Osteosarcoma of the Jaw and Its Relationship to Lymph Node Metastasis

The Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinases 2,9 in Osteosarcoma

LncRNA SATB2-AS1 Promotes Tumor Growth and Metastasis and Affects the Tumor Immune Microenvironment in Osteosarcoma by Regulating SATB2

BMPR2 Promotes Invasion and Metastasis Via the RhoA-ROCK-LIMK2 Pathway in Human Osteosarcoma Cells.

[Intrathyroid iodine metabolism and biological half-life of T4 in children].

Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma

Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy.

Identification of Tumorigenicity-Associated Genes in Osteosarcoma Cell Lines Based on Bioinformatic Analysis and Experimental Validation.

Expression of Hypoxia-Inducible Factor 1α in Osteosarcoma and Its Value in Predicting Chemosensitivity

Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.

Increased Expression of Insulin-Like Growth Factor-1 Receptor is Correlated with Tumor Metastasis and Prognosis in Patients with Osteosarcoma

PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma

HIF-1α-mediated augmentation of miRNA-18b-5p facilitates proliferation and metastasis in osteosarcoma through attenuation PHF2

Correlation Between Pathological Features and Protein Expressions of TfR1, VEGF and MMP-9 in Patients with Osteosarcoma

Predictive Significance of Bone Sialoprotein and Osteopontin for Bone Metastases in Respectable Non-Small Cell Lung Cancer: A Retrospective Study

Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.

Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma

Expressions of RECK mRNA and MMP-2 mRNA in osteosarcoma and their clinical significance

Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15